Intel Corporation (INTC)
NASDAQ: INTC · Real-Time Price · USD
19.50
+0.19 (0.98%)
At close: Aug 4, 2025, 4:00 PM
19.50
0.00 (0.00%)
After-hours: Aug 4, 2025, 7:59 PM EDT
ShockWave Medical Stock Forecast
Stock Price Forecast
The 25 analysts that cover ShockWave Medical stock have a consensus rating of "Hold" and an average price target of $22.42, which forecasts a 14.97% increase in the stock price over the next year. The lowest target is $14 and the highest is $29.
Price Target: $22.42 (+14.97%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for ShockWave Medical stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 25 | 26 | 24 | 22 | 22 | 23 |
| Sell | 2 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 2 | 2 | 4 | 4 | 4 | 4 |
| Total | 30 | 30 | 30 | 28 | 28 | 29 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Sell Maintains $20 → $21 | Sell | Maintains | $20 → $21 | +7.69% | Jul 25, 2025 |
| Rosenblatt | Rosenblatt | Strong Sell Maintains $14 | Strong Sell | Maintains | $14 | -28.21% | Jul 25, 2025 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jul 25, 2025 |
| Benchmark | Benchmark | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jul 25, 2025 |
| Loop Capital | Loop Capital | Hold Initiates $25 | Hold | Initiates | $25 | +28.21% | Jul 21, 2025 |
Financial Forecast
Revenue This Year
52.95B
from 53.10B
Decreased by -0.29%
Revenue Next Year
55.02B
from 52.95B
Increased by 3.91%
EPS This Year
0.30
from -4.38
EPS Next Year
0.79
from 0.30
Increased by 160.27%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 56.5B | 62.3B | 64.4B | ||
| Avg | 52.9B | 55.0B | 57.7B | ||
| Low | 49.2B | 49.5B | 50.6B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 6.4% | 17.7% | 17.0% | ||
| Avg | -0.3% | 3.9% | 4.9% | ||
| Low | -7.3% | -6.5% | -8.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 0.83 | 1.37 | 2.18 | ||
| Avg | 0.30 | 0.79 | 1.41 | ||
| Low | 0.01 | 0.24 | 0.56 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 349.5% | 176.3% | ||
| Avg | - | 160.3% | 77.9% | ||
| Low | - | -22.5% | -29.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.